Eva Gimeno Vázquez, MD

Department of Hematology, Hospital del Mar, Spain

N/A

Poster(s):

• 1118 - Optical genome mapping identifies a high number of chromoanagenesis events in chronic lymphocytic leukemia patients with altered TP53

• 1430 - Assessing measurable residual disease (MRD) by cell-free DNA (cfDNA): results from a real-world series

• 1438 - Central Nervous System Involvement in Chronic Lymphocytic Leukemia: An International Retrospective Study by ERIC, the European Research Initiative on CLL